Natural extracellular vesicles containing ACE2 protein could fight new SARS-CoV-2 variants

Scientists at The University of Texas MD Anderson Cancer Center and Northwestern Medicine have identified natural extracellular vesicles containing the ACE2 protein (evACE2) in the blood of COVID-19 patients that can block infection from broad strains of SARS-CoV-2 virus in preclinical studies. The study was published today in Nature Communications.

Related Keywords

Texas ,United States ,Raghu Kalluri ,Deyu Fang ,Huiping Liu ,Emily Henderson ,Kathleen Mcandrews ,Nature Communications ,University Of Texas Md Anderson Cancer Center ,Northwestern University Feinberg School Of Medicine ,Cancer Center ,Northwestern Medicine ,Northwestern University Feinberg School ,Cancer Biology ,Co Lead Author ,Postdoctoral Fellow ,Ace2 ,Eceptor ,Cars ,Ars Cov 2 ,Antibodies ,Flood ,Dancer ,Fell ,Covid 19 ,Efficacy ,Medicine ,Pathology ,Mh ,Harmacology ,Reclinical ,Protein ,Herapeutics ,Vaccine ,Virus ,